Novo Nordisk A/S (NYSE:NVO) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Novo Nordisk A/S (NYSE:NVO – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten research firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong […]
Shares of Novo Nordisk A/S (NYSE:NVO – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten research firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong […]
